the Web site devoted to the study of the glucagon-like peptides
This Web site is maintained by Dr. Daniel J. Drucker, Mount Sinai Hospital Samuel Lunenfeld Research Institute University of Toronto
Exenatide efficacy in human subjects with Parkinson's disease GLP-1 action in the CNS
Updated pooled analysis of sitagliptin safety from 25 clinical trials GLP-1 Adverse Events
For updates to glucagon.com, Follow us on Twitter DanielJDrucker
